Cited by 1,347COVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentLong-Term Effects of COVID-19

D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19

Open access
Zhang, Litao, Yan, Xinsheng, Fan, Qingkun, Liu, Haiyan, Liu, Xintian, Liu, Zejin, Zhang, Zhenlu·2020·Journal of Thrombosis and Haemostasis

Abstract

Background The outbreak of the coronavirus disease 2019 (Covid-19) has shown a global spreading trend. Early and effective predictors of clinical outcomes are urgently needed to improve management of Covid-19 patients.Objective The aim of the present study was to evaluate whether elevated D-dimer levels could predict mortality in patients with Covid-19.Methods Patients with laboratory confirmed Covid-19 were retrospective enrolled in Wuhan Asia General Hospital from January 12, 2020, to March 15, 2020. D-dimer levels on admission and death events were collected to calculate the optimum cutoff using receiver operating characteristic curves. According to the cutoff, the subjects were divided into two groups. Then the in-hospital mortality between two groups were compared to assess the predictive value of D-dimer level.Results A total of 343 eligible patients were enrolled in the study. The optimum cutoff value of D-dimer to predict in-hospital mortality was 2.0 µg/mL with a sensitivity of 92.3% and a specificity of 83.3%. There were 67 patients with D-dimer ≥2.0 µg/mL, and 267 patients with D-dimer <2.0 µg/mL on admission. 13 deaths occurred during hospitalization. Patients with D-dimer levels ≥2.0 µg/mL had a higher incidence of mortality when comparing with those who with D-dimer levels <2.0 µg/mL (12/67 vs 1/267, P < .001; hazard ratio, 51.5; 95% confidence interval, 12.9-206.7).Conclusions D-dimer on admission greater than 2.0 µg/mL (fourfold increase) could effectively predict in-hospital mortality in patients with Covid-19, which indicated D-dimer could be an early and helpful marker to improve management of Covid-19 patients. (Chinese Clinical Trial Registry: ChiCTR2000031428).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jth.14859

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The CDS model used chest X-ray images, vital signs, demographic data, and laboratory values that prior publications showed to be predictive of COVID-19 outcomes.

    “The inputs to the CDS model were Chest X-Ray (CXR) images, vital signs, demographic data, and lab values that were shown in previous publications to be predictive of COVID-19 patient outcomes18–21.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z.
Affiliations
Wuhan Asia Heart Hospital (CN)
Corresponding author
Zhang, Zhenlu
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2020-06
Volume
18
Issue
6
Pages
1324-1329
ISSN
1538-7836 (ISSN-L)
OpenAlex
W3016508437
Cited by
1,347
References
25
Citations by year
2026: 21 · 2025: 48 · 2024: 92 · 2023: 158 · 2022: 287 · 2021: 426 · 2020: 312
FWCI
38.75
Type
journal article
Language
en
Open access
Locations
  • Journal of Thrombosis and Haemostasis (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
D-dimer, COVID-19 pandemic, in-hospital mortality, prognostic factors, mortality prediction, diagnostic thresholds, thrombosis
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Female, Fibrin Fibrinogen Degradation Products, Humans, Male, Middle Aged, Patient Admission, Pneumonia, Viral, Predictive Value of Tests, Prognosis, Retrospective Studies, Risk Factors, Time Factors, Biomarkers, Hospital Mortality, Coronavirus Infections, Risk Assessment, Early Diagnosis, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review